27746068|t|Targeting postprandial blood sugar over fasting blood sugar: A clinic based comparative study
27746068|a|Recent studies indicate that modulation of post prandial blood sugar (PPBS) plays an important role in the long term glycemic control. Measurement of PPBS is more convenient for patients attending outpatient clinics than fasting blood sugar (FBS) as the former needs only two hours of fasting from the last meal. To assess the value of PPBS monitoring in optimization of long term glycemic control among diabetic patients attending an outpatient clinic. A total of 240 patients with type 2 diabetes (T2DM) attending an out-patient medical clinic were randomized to either PPBS or FBS monitoring. Those who selected to PPBS - group underwent blood sugar measurement 2-h after last meal on the day of their clinic visits and those in the FBS group underwent blood sugar measurement after fasting overnight (8-10h) in the morning of their clinic visits. Treating team was asked to optimize the anti-diabetic medications based on the available PPBS or FBS results. All patients were followed up monthly for six months. Glycemic control was assessed with glycosylated hemoglobin (HbA1c) at baseline and six months later. Baseline characteristics of the two arms including age, gender, and duration of T2DM were not significantly different. Mean HbA1c (SD) of FBS and PPBS arms at baseline were 7.20 (0.45), and 7.33 (0.43) and were not significantly different (P=0.115). During the study period, HbA1c dropped by 0.20 in FBS arm compared to 0.25 drop in PPBS arm (p=0.59). Incidence of hypoglycemia was similar in FBS (2.42%) and PPBS arms (2.70%). Monitoring of PPBS is a safe and effective alternative to FBS to optimize glycemic control in managing patients with T2DM attending outpatient clinics.
27746068	0	9	Targeting	T169	C1521840
27746068	10	34	postprandial blood sugar	T059	C0428569
27746068	40	59	fasting blood sugar	T059	C2825162
27746068	63	93	clinic based comparative study	T062	C1579762
27746068	123	133	modulation	T080	C0205419
27746068	137	162	post prandial blood sugar	T047	C0271710
27746068	164	168	PPBS	T047	C0271710
27746068	201	210	long term	T079	C0443252
27746068	211	227	glycemic control	T061	C3267174
27746068	229	248	Measurement of PPBS	T059	C0428569
27746068	257	267	convenient	T080	C3831015
27746068	272	280	patients	T101	C0030705
27746068	281	290	attending	T169	C0730262
27746068	291	309	outpatient clinics	T073,T093	C0029916
27746068	315	334	fasting blood sugar	T059	C2825162
27746068	336	339	FBS	T059	C2825162
27746068	355	360	needs	T080	C0027552
27746068	379	386	fasting	T033	C0015663
27746068	396	405	last meal	T033	C0578574
27746068	410	416	assess	T058	C0184514
27746068	430	434	PPBS	T059	C0428569
27746068	435	445	monitoring	T058	C1283169
27746068	449	461	optimization	T052	C2698650
27746068	465	474	long term	T079	C0443252
27746068	475	491	glycemic control	T061	C1638311
27746068	498	515	diabetic patients	T101	C0030705
27746068	516	525	attending	T169	C0730262
27746068	529	546	outpatient clinic	T073,T093	C0029916
27746068	563	571	patients	T101	C0030705
27746068	577	592	type 2 diabetes	T047	C0011860
27746068	594	598	T2DM	T047	C0011860
27746068	600	609	attending	T169	C0730262
27746068	613	639	out-patient medical clinic	T073,T093	C0029916
27746068	645	655	randomized	T033	C3815594
27746068	666	670	PPBS	T059	C0428569
27746068	674	677	FBS	T059	C2825162
27746068	678	688	monitoring	T058	C1283169
27746068	712	716	PPBS	T047	C0271710
27746068	719	724	group	T078	C0441833
27746068	735	758	blood sugar measurement	T059	C0428566
27746068	769	778	last meal	T056	C4048877
27746068	799	812	clinic visits	T058	C0008952
27746068	830	833	FBS	T047	C0271708
27746068	834	839	group	T078	C0441833
27746068	850	887	blood sugar measurement after fasting	T059	C2825162
27746068	888	897	overnight	T079	C0439583
27746068	913	920	morning	T079	C0332170
27746068	930	943	clinic visits	T058	C0008952
27746068	945	958	Treating team	T097	C4054830
27746068	985	1010	anti-diabetic medications	T121	C0935929
27746068	1034	1038	PPBS	T034	C1318329
27746068	1042	1053	FBS results	T034	C1261430
27746068	1059	1067	patients	T101	C0030705
27746068	1073	1084	followed up	T058	C1522577
27746068	1085	1092	monthly	T079	C0332177
27746068	1097	1107	six months	T079	C4082120
27746068	1109	1125	Glycemic control	T061	C3267174
27746068	1144	1167	glycosylated hemoglobin	T116,T123	C0019018
27746068	1169	1174	HbA1c	T116,T123	C0019018
27746068	1179	1187	baseline	T081	C1442488
27746068	1192	1208	six months later	T079	C4082120
27746068	1210	1218	Baseline	T081	C1442488
27746068	1261	1264	age	T032	C0001779
27746068	1266	1272	gender	T032	C0079399
27746068	1278	1286	duration	T079	C0872146
27746068	1290	1294	T2DM	T047	C0011860
27746068	1300	1317	not significantly	T033	C1273937
27746068	1318	1327	different	T080	C1705242
27746068	1334	1339	HbA1c	T116,T123	C0019018
27746068	1348	1351	FBS	T059	C2825162
27746068	1356	1360	PPBS	T059	C0428569
27746068	1421	1438	not significantly	T033	C1273937
27746068	1439	1448	different	T080	C1705242
27746068	1485	1498	HbA1c dropped	T033	C0855304
27746068	1510	1513	FBS	T059	C0428568
27746068	1543	1547	PPBS	T059	C0428569
27746068	1562	1571	Incidence	T081	C0021149
27746068	1575	1587	hypoglycemia	T047	C0020615
27746068	1603	1606	FBS	T059	C2825162
27746068	1619	1623	PPBS	T059	C0428569
27746068	1638	1648	Monitoring	T058	C1283169
27746068	1652	1656	PPBS	T047	C0271710
27746068	1671	1680	effective	T080	C1704419
27746068	1681	1692	alternative	T077	C1523987
27746068	1696	1699	FBS	T059	C2825162
27746068	1703	1711	optimize	T052	C2698650
27746068	1712	1728	glycemic control	T061	C3267174
27746068	1732	1740	managing	T058	C3165354
27746068	1741	1749	patients	T101	C0030705
27746068	1755	1759	T2DM	T047	C0011860
27746068	1760	1769	attending	T169	C0730262
27746068	1770	1788	outpatient clinics	T073,T093	C0029916